New pill could boost red blood cells in sickle cell patients
NCT ID NCT07282210
First seen Jan 06, 2026 · Last updated May 06, 2026 · Updated 21 times
Summary
This study tests an experimental drug called SIL-8301 (senicapoc) in about 105 adults with sickle cell disease who have severe anemia and few pain crises. Participants take the drug or a placebo daily for 24 weeks, while continuing their usual hydroxyurea treatment. The main goal is to see if the drug raises hemoglobin levels by at least 1 g/dL, which could reduce complications and improve quality of life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SICKLE CELL DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.